We are the leading domestic pharmaceutical company in Russia and and the third largest pharmaceutical company operating in Russia overall. We develop, manufacture, market and sell generic pharmaceutical products in various formulations, primarily in Russia. Our product portfolio includes market-leading brands, such as Pentalgin® (analgesics), Arbidol® (anti-viral for systemic use), Terpincod® (cough and cold), Complivit® (vitamins) and Flucostat® (antifungal). Our pharmaceutical product portfolio includes products that do not require a medical prescription (“over-the-counter” or “OTC” products), as well as prescription drugs. OTC products accounted for 85% of our pharmaceutical product sales in 2007. Our pharmaceutical product portfolio covers a wide range of therapeutic segments. Our pharmaceutical product portfolio consists of both branded generics, which may be trademarked and which we promote through our direct sales force, and non-branded, or “pure”, generics, which are older products that have demonstrated sustainable demand from consumers without the need for continued active promotion. Pharmaceutical products accounted for 86% of our sale of goods in 2007.